Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
31.62 EUR | +0.33% |
|
+0.59% | -10.20% |
Strengths
- The company has a low valuation given the cash flows generated by its activity.
- The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- The company's earnings growth outlook lacks momentum and is a weakness.
- The company is in a hindered financial situation with significant debt and rather low EBITDA levels.
- The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
- The overall consensus opinion of analysts has deteriorated sharply over the past four months.
- The price targets of various analysts who make up the consensus differ significantly. This reflects different assessments and/or a difficulty in valuing the company.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-10.20% | 1.73TCr | - | ||
-4.72% | 18TCr | C+ | ||
-2.83% | 10TCr | C | ||
-5.01% | 6.69TCr | A | ||
+15.53% | 4.67TCr | B- | ||
-8.53% | 4.51TCr | B- | ||
+5.82% | 4.16TCr | B+ | ||
+17.67% | 3.05TCr | B | ||
+14.00% | 2.43TCr | A- | ||
-8.08% | 2.36TCr | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- BAX Stock
- BAX Stock
- Ratings Baxter International Inc.